Marker Therapeutics (MRKR) EBIT Margin (2017 - 2025)
Marker Therapeutics (MRKR) posted EBIT Margin of -170.74% for Q4 2025, up 0.75 percentage points from -171.48% a year earlier and up 2.57 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) EBIT Margin (2017 - 2025) Analysis & Trends
For FY2025, Marker Therapeutics' EBIT Margin came in at -363.45%, down 194.76 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +5413.71 percentage points (FY2020 to FY2025).
- In prior years, Marker Therapeutics' EBIT Margin was -168.69% in FY2024 (+271.69 pp), -440.37% in FY2023 (+122.90 pp), -563.28% in FY2022 (+2616.05 pp) and -3179.32% in FY2021 (+2597.84 pp).
- The Q4 2025 figure stands as the highest quarterly EBIT Margin since Q3 2024.
- On a year-over-year basis, EBIT Margin increased in three of the last seven quarters, with an average year-over-year change of -66.99 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q3 2024, with a gain of 1117.62 percentage points; the weakest was Q1 2025, with a drop of 1215.25 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -173.30% (Q3 2025), -594.79% (Q2 2025) and -1420.14% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -170.74% |
| Sep 30, 2025 | -173.30% |
| Jun 30, 2025 | -594.79% |
| Mar 31, 2025 | -1,420.14% |
| Dec 31, 2024 | -171.48% |
| Sep 30, 2024 | -124.60% |
| Jun 30, 2024 | -197.40% |
| Mar 31, 2024 | -204.89% |
| Dec 31, 2023 | -278.06% |
| Sep 30, 2023 | -1,242.22% |
| Dec 31, 2022 | -400.28% |
| Sep 30, 2022 | -582.90% |
| Jun 30, 2022 | -666.47% |
| Mar 31, 2022 | -1,015.71% |
| Dec 31, 2020 | -25,616.37% |
| Jun 30, 2020 | -1,361.99% |
| Dec 31, 2019 | -2,515.10% |
| Jun 30, 2018 | -2,268.90% |
| Sep 30, 2017 | -2,179.30% |
API Access
Marker Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();